the patient is the boss: dr. mark pomerantz | dana-farber cancer institute
Published 12 years ago • 4K plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:38
what is a prostate cancer biomarker?
-
8:44
finding an oncologist for advanced disease | scanning for metastases early | mark scholz, md | pcri
-
1:17
prince: 177lu-psma-617 and pembrolizumab in prostate cancer
-
2:16
geoffrey box, md, on prostate cancer | ohio state medical center
-
21:55
dr christian frezza - mitochondrial dysfunction in cancer
-
19:11
theranostics: the future for prostate cancer treatment is here!!
-
23:20
intermediate-risk prostate cancer treatment - musc hollings
-
18:14
precision cancer medicine | professor andrew biankin
-
9:05
sac spotlight series: dr alan olivero
-
2:17
advanced prostate cancer and patient-centric treatment
-
1:06
peter forsyth, md, ma - neuro-oncology
-
36:06
progress towards a biomarker based diagnosis of msa - edwin george, md, phd
-
3:02
pete: prostate cancer
-
2:42
targeted prostate biopsy at stanford hospital featuring geoffrey sonn, m.d.
-
2:12
state department dr. peter molberg recommends prudence on use of potassium iodide
-
16:13
advancements in the diagnosis and treatment of patients with prostate cancer
-
16:30
how metabolic therapy checkmates cancer
-
1:01:59
richard lu: opcs and oligodendrocytes – roles in brain development, function, and cancer
-
9:28
immray™ technology
-
0:42
dr. rathkopf on ar-v7 biomarker in prostate cancer
-
3:31
prof. richard stone | ebmt 2018 | latest advances in monitoring mrd in aml
-
20:32
prostate cancer treatment update 2021